"Onkologie" . "Biologick\u00E1 l\u00E9\u010Dba karcinomu prsu"@cs . . . "305190" . "RIV/00064165:_____/09:4182" . . "CZ - \u010Cesk\u00E1 republika" . . "9"^^ . "Biological therapy for breast cancer"@en . "1"^^ . "Biologick\u00E1 l\u00E9\u010Dba karcinomu prsu" . . "3" . "1"^^ . "Biologick\u00E1 l\u00E9\u010Dba karcinomu prsu"@cs . . "RIV/00064165:_____/09:4182!RIV10-MZ0-00064165" . . "[885D1E850070]" . . . "Sou\u010Dasn\u00E1 \u00E9ra c\u00EDlen\u00E9 onkologick\u00E9 l\u00E9\u010Dby tzv. \u201E\u0161it\u00E9 na m\u00EDru\u201C byla ve sv\u00E9 podstat\u011B zapo\u010Data po objevu hormon\u00E1ln\u00EDch receptor\u016F a c\u00EDlen\u00E9ho klinick\u00E9ho pou\u017Eit\u00ED tamoxifenu. Prvn\u00ED klinick\u00E9 pou\u017Eit\u00ED trastuzumabu v kombinaci s chemoterapi\u00ED u metastazuj\u00EDc\u00EDho karcinomu prsu zapo\u010Dalo \u00E9ru bioregula\u010Dn\u00ED nehormon\u00E1ln\u00ED l\u00E9\u010Dby karcinomu prsu. C\u00EDlen\u00E1 molekul\u00E1rn\u00ED l\u00E9\u010Dba nen\u00ED ji\u017E jen p\u0159edm\u011Btem v\u00FDzkumu, ale je ji\u017E realitou v klinick\u00E9 praxi v l\u00E9\u010Db\u011B karcinomu prsu." . "Petru\u017Eelka, Lubo\u0161" . . "Biological therapy for breast cancer"@en . "Biologick\u00E1 l\u00E9\u010Dba karcinomu prsu" . "1802-4475" . "The contemporary era of targeted, so-called %22patient-tailored%22, oncological therapy essentially began upon the discovery of hormonal receptors and targeted clinical use of tamoxifen. Initial clinical use of trastuzumab in combination with chemotherapy in metastatic breast cancer started the era of bioregulatory nonhormonal therapy for breast cancer (12). Targeted molecular therapy is no longer a mere subject of research but a reality in the clinical practice of breast cancer treatment."@en . "Sou\u010Dasn\u00E1 \u00E9ra c\u00EDlen\u00E9 onkologick\u00E9 l\u00E9\u010Dby tzv. \u201E\u0161it\u00E9 na m\u00EDru\u201C byla ve sv\u00E9 podstat\u011B zapo\u010Data po objevu hormon\u00E1ln\u00EDch receptor\u016F a c\u00EDlen\u00E9ho klinick\u00E9ho pou\u017Eit\u00ED tamoxifenu. Prvn\u00ED klinick\u00E9 pou\u017Eit\u00ED trastuzumabu v kombinaci s chemoterapi\u00ED u metastazuj\u00EDc\u00EDho karcinomu prsu zapo\u010Dalo \u00E9ru bioregula\u010Dn\u00ED nehormon\u00E1ln\u00ED l\u00E9\u010Dby karcinomu prsu. C\u00EDlen\u00E1 molekul\u00E1rn\u00ED l\u00E9\u010Dba nen\u00ED ji\u017E jen p\u0159edm\u011Btem v\u00FDzkumu, ale je ji\u017E realitou v klinick\u00E9 praxi v l\u00E9\u010Db\u011B karcinomu prsu."@cs . "Breast cancer; targeted biological therapy; trastuzumab; lapatinib; bevacizumab"@en . "1" . . . . . . . "V" .